Andrew A. Hindman Theravance Biopharma, Inc. (TBPH) insider trading activity

Andrew A. Hindman is SVP, CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc.. Currently has a direct ownership of 384,714 shares of TBPH, which is worth approximately $3.69 Million. The most recent transaction as insider was on Nov 20, 2022, when has been sold 25,057 shares (Ordinary Shares) at a price of $10.85 per share, resulting in proceeds of $271,868. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 385K

0% 3M change

0% 12M change

Total Value Held $3.69 Million

Andrew A. Hindman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2022	SELL Payment of exercise price or tax liability	$271,868 $10.85 p/Share	25,057 Reduced 6.11%	384,714 Ordinary Shares
Nov 18 2022	SELL Open market or private sale	$716,300 $11.02 p/Share	65,000 Reduced 13.69%	409,771 Ordinary Shares
Aug 19 2022	SELL Payment of exercise price or tax liability	$239,814 $9.34 p/Share	25,676 Reduced 5.14%	473,507 Ordinary Shares
Jul 25 2022	BUY Grant, award, or other acquisition	-	20,000 Added 3.85%	499,183 Ordinary Shares
May 20 2022	SELL Payment of exercise price or tax liability	$29,410 $8.74 p/Share	3,365 Reduced 0.7%	479,183 Ordinary Shares
Feb 18 2022	SELL Payment of exercise price or tax liability	$249,601 $9.61 p/Share	25,973 Reduced 5.12%	481,285 Ordinary Shares
Dec 02 2021	BUY Grant, award, or other acquisition	-	340,000 Added 40.13%	507,258 Ordinary Shares
Nov 19 2021	SELL Payment of exercise price or tax liability	$11,286 $8.36 p/Share	1,350 Reduced 0.8%	167,258 Ordinary Shares
Aug 20 2021	SELL Payment of exercise price or tax liability	$245,369 $14.05 p/Share	17,464 Reduced 9.45%	167,380 Ordinary Shares
May 20 2021	SELL Payment of exercise price or tax liability	$16,768 $17.8 p/Share	942 Reduced 0.51%	184,844 Ordinary Shares
Feb 20 2021	SELL Payment of exercise price or tax liability	$74,859 $18.79 p/Share	3,984 Reduced 2.11%	184,704 Ordinary Shares
Feb 08 2021	BUY Grant, award, or other acquisition	-	65,000 Added 25.62%	188,688 Ordinary Shares

AAH

Andrew A. Hindman

SVP, CHIEF FINANCIAL OFFICER

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account